The role of hypertension, body mass index, and serum leptin levels in patients with endometrial hyperplasia during premenopausal period

Clinical and Experimental Obstetrics and Gynecology

Volumn 39, Issue 3, 2012, Pages 321-325

  Balbi, G ^a   Napolitano, A ^a   Seguino, E ^a   Scaravilli, G ^a   Gioia, F ^a   Di Martino, L ^a   Fusco, D ^a   Signoriello, G ^a   Grauso, F ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

BMI; Diabetes; Endometrial hyperplasia; Hypertension; Leptin

Indexed keywords

LEPTIN;

ADULT; AGE; ANTHROPOMETRIC PARAMETERS; ARTICLE; BODY FAT DISTRIBUTION; BODY MASS; CONTROLLED STUDY; CORRELATION ANALYSIS; DEMOGRAPHY; DIABETES MELLITUS; ENDOMETRIUM HYPERPLASIA; FEMALE; HUMAN; HYPERTENSION; IMMUNOCHEMISTRY; LIFESTYLE; MAJOR CLINICAL STUDY; PHYSICAL ACTIVITY; PREMENOPAUSE; PREVALENCE; RISK FACTOR; WAIST CIRCUMFERENCE; WAIST HIP RATIO;

ADULT; AGE FACTORS; BODY MASS INDEX; ENDOMETRIAL HYPERPLASIA; EXERCISE; FEMALE; HUMANS; HYPERTENSION; LEPTIN; MIDDLE AGED; OBESITY; PREMENOPAUSE; RISK FACTORS; WAIST-HIP RATIO;

EID: 84867164645     PISSN: 03906663     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Ash S.J., Farrell S.A., Flowerdew G.: "Endometrial biopsy in DUB". J. Reprod. Med., 1996, 41, 892.
2. Vercellini P., Cortesi I., Oldani S., Moschetta M., De Giorgi O., Crosignani P.G.: "The role of transvaginal ultrasonography and outpatient diagnostic hysteroscopy in the evaluation of patients with menorrhagia". Hum. Reprod., 1997, 12, 1768.
3. Reed S.D., Newton K.M., Clinton W.L., Epplein M., Garcia R., Allison K., Voigt L.F., Weiss N.S.: "Incidence of endometrial hyperplasia". Am. J. Obstet. Gynecol., 2009, 200, 678 e1-678.
4. Kurman R.J., Kaminski P.F., Norris H.J.: "The behavior of endometrial hyperplasia. A long-term study of "untreated" hyperplasia in 170 patients". Cancer, 1985, 56, 403.
5. Tavassoli F.A. World Health Organization Classification of Tumors: "Pathology and Genetics of Tumors of the Breast and Female Genital Organs". Lyon, IARC Press, 2003.
6. Gol K., Saracoglu F., Ekici A., Sahin I.: "Endometrial patterns and endocrinologic characteristics of asymptomatic menopausal women". Gynecol. Endocrinol., 2001, 15, 63.
7. Korhonen M.O., Symons J.P., Hyde B.M., Rowan J.P., Wilborn W.H.: "Histologic classification and pathologic findings for endometrial biopsy specimens obtained from 2964 perimenopausal and postmenopausal women undergoing screening for continuous hormones as replacement therapy (CHART 2 Study)". Am. J. Obstet. Gynecol., 1997, 176, 377.
8. Boden G.: "Free fatty acids-the link between obesity and insulin resistance" (Review). Endocr. Pract., 2001, 7, 44.
9. Roth J., Qiang X., Marbán S.L., Redelt H., Lowell B.C.: "The obesity pandemic: where have we been and where are we going?". Obstet. Res., 2004, 12 (suppl. 2), 88S.
10. Kurman R.J., Kaminski P.F., Norris H.J.: "The behavior of endometrial hyperplasia. A long-term study of "untreated" hyperplasia in 170 patients". Cancer, 1985, 56, 403.
11. Farquhar C.M., Lethaby A., Sowter M., Verry J., Baranyai J.: "An evaluation of risk factors for endometrial hyperplasia in premenopausal women with abnormal menstrual bleeding". Am. J. Obstet. Gynecol., 1999, 181, 525.
12. Fraser I.S., Critchley H.O., Munro M.G., Broder M.: "Can we achieve international agreement on terminologies and definitions used to describe abnormalities of menstrual bleeding?". Hum. Reprod., 2007, 22, 635.
13. Ozdemir S., Celik C, Gezginç K., Kireşj D., Esen H.: "Evaluation of endometrial thickness with transvaginal ultrasonography and histopathology in premenopausal women with abnormal vaginal bleeding". Arch. Gynecol. Obstet., 2010, 282, 395.
14. Bettocchi S., Nappi L., Ceci O., Selvaggi L.: "What does 'diagnostic hysteroscopy' mean today? The role of the new techniques" (Review). Curr. Opin. Obstet. Gynecol., 2003, 15, 303.
15. Lapidus L., Bengtsson C., Larsson B., Pennert K., Rybo E., Sjöström L.: "Distribution of adipose tissue and risk of cardiovascular disease and death: a 12 year follow-up of participants in the population study of women in Gothenburg, Sweden". Br. Med. J. (Clin Res Ed), 1984, 289, 1257.
16. American Diabetes Association: Diagnosis and Classification of Diabetes Mellitus. Diabetes Care, 2010, 33 (suppl. 1), S62.
17. Hobanian A.V., Bakris G.L. et al.: "Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure". Hypertension., 2003, 42, 1206.
18. Anastasiadis P.G., Skaphida P.G., Koutlaki N.G., Galazios G.C., Tsikouras P.N., Liberis V.A.: "Descriptive epidemiology of endometrial hyperplasia in patients with abnormal uterine bleeding". Eur. J. Gynaecol. Oncol., 2000, 21, 131.
19. Taddei G.L., Bargelli G., Scarselli B., Moncini D., Scarselli G.: "Precancerous lesions of the endometrium and medical treatment". Eur. J. Contracept. Reprod. Health Care, 1997, 2, 239.
20. Pi-Sunyer F.X.: "The practical guide: Identification, evaluation, and treatment of overweight and obesity in adults". NIH Publication No. 00-4084, 2000.
21. Kaye S.A., Folsom A.R., Soler J.T., Prineas R.J., Potter J.D.: "Association of body mass and fat distribution with sex hormone concentrations in postmenopausal women". Int. J. Epidemiol., 1991, 20, 151.
22. MacDonald P.C., Edman C.D., Hemsell D.L., Porter J.C., Siiteri P.K.: "Effect of obesity on conversion of plasma androstenedione to estrone in postmenopausal women with and without endometrial cancer". Am. J. Obstet. Gynecol., 1978, 130, 448.
23. Sherman B.M., Korenman S.G.: "Measurement of serum LH, FSH, estradiol and progesterone in disorders of the human menstrual cycle: the inadequate luteal phase". J. Clin. Endocrinol. Metab., 1974, 39, 145.
24. Teitelman M., Grotegut C.A., Williams N.N., Lewis J.D.: "The impact of bariatric surgery on menstrual patterns". Obstet. Surg., 2006, 16, 1457.
25. Heller D.S., Mosquera C., Goldsmith L.T., Cracchiolo B.: "Body mass index of patients with endometrial hyperplasia: comparison to patients with proliferative endometrium and abnormal bleeding". J. Reprod. Med., 2011, 56, 110.
26. Vorgias G., Strigou S., Varhalama E., Savvopoulos P., Dertimas B., Akrivos T.: "The effect of hypertension and anti-hypertensive drugs on endometrial thickness and pathology". Eur. J. Obstet. Gynecol. Reprod. Biol., 2006, 125, 239.
27. Al-Jarrah M., Matalka I., Aseri H.A., Mohtaseb A., Smirnova I.V., Novikova L., Stehno-Bittel L., Alkhateeb A.: "Exercise training prevents endometrial hyperplasia and biomarkers for endometrial cancer in rat model of type 1 diabetes". J. Clin. Med. Res., 2010, 2, 207.
28. Epplein M., Reed S.D., Voigt L.F., Newton K.M., Holt V.L., Weiss N.S.: "Risk of complex and atypical endometrial hyperplasia in relation to anthropometric measures and reproductive history". Am J Epidemiol., 2008, 168, 563.
29. Petridou E., Belechri M., Dessypris N., Koukoulomatis P., Diakomanolis E., Spanos E., Trichopoulos D.: "Leptin and body mass index in relation to endometrial cancer risk". Ann. Nutr. Metab., 2002, 46, 147.
30. Cymbaluk A., Chudecka-Głaz A., Rzepka-Górska I.: "Leptin levels in serum depending on Body Mass Index in patients with endometrial hyperplasia and cancer". Eur. J. Obstet. Gynecol. Reprod. Biol., 2008, 136, 74.
31. Yuan S.S., Tsai K.B., Chung Y.F., Chan T.F., Yeh Y.T., Tsai L.Y., Su J.H.: "Aberrant expression and possible involvement of the leptin receptor in endometrial cancer". Gynecol. Oncol., 2004, 92, 769.
32. Tajtakova M., Petrasova D., Pidanicova A., Gallovicova A., Blanarova C., Petrovicova J.: "Serum levels of leptin, adiponectin, retinol binding protein 4 and leptin/adiponectin molar ratio as another possible marker of insulin resistance in obese". Bratisl Lek. Listy., 2010, 111, 212.
33. Ushiroyama T., Ikeda A., Higashio S., Sakuma K., Ueki M.: "Elevated plasma leptin levels associated with high blood pressure and TG rich lipoproteins but not associated with plasma gonadotropins, estradiol and cortisol levels in peri- and postmenopausal lean women with undefined symptoms". J. Med., 2004, 35, 63.